Alicia J. Hager is CLO & VP at OncoMed Pharmaceuticals Inc (OMED). They have made 12 open-market trades across 2 companies since 2015, most recently 2025-01-15.
CIK 0001302573
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NKTX | SELL | 2025-01-15 | 2025-01-17 | $2.20 | $21K | -5.6% | -9.2% | -27.6% |
| NKTX | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $8.00 | $27K | -4.9% | -22.0% | -35.0% |
| NKTX | SELL | 2024-06-18 | 2024-06-20 | $5.60 | $4K | -1.5% | +21.2% | -1.3% |
| NKTX | SELL | 2024-01-16 | 2024-01-18 | $8.74 | $40K | +10.0% | +23.0% | -6.3% |
| NKTX | SELL | 2023-06-20 | 2023-06-22 | $4.85 | $3K | -53.2% | -52.5% | -62.5% |
| NKTX | SELL | 2023-01-17 | 2023-01-18 | $5.49 | $6K | -1.4% | +5.6% | -7.2% |
| OMED | SELL | 2018-10-10 | 2018-10-11 | $2.02 | $2K | +2.0% | -27.8% | -62.6% |
| OMED | SELL | 2018-10-09 | 2018-10-10 | $2.13 | $4K | +15.5% | -20.5% | -61.0% |
| OMED | SELL | 2018-04-24 | 2018-04-26 | $2.68 | $11K | -1.0% | -3.6% | -28.8% |
| OMED | SELL | 2017-10-10 | 2017-10-12 | $4.24 | $5K | -11.1% | +7.7% | -32.1% |
| OMED | SELL | 2017-04-04 | 2017-04-05 | $9.06 | $39K | -55.9% | -58.7% | -59.5% |
| OMED | SELL | 2017-03-15 | 2017-03-17 | $10.00 | $67K | -7.1% | -59.9% | -64.1% |
| OMED | SELL | 2016-01-06 | 2016-01-08 | $22.28 | $72K | -18.1% | -55.5% | -47.5% |
| OMED | SELL · 10b5-1 | 2015-11-27 | 2015-12-01 | $23.14 | $42K | -32.1% | -0.5% | -56.9% |
| OMED | SELL · 10b5-1 | 2015-10-27 | 2015-10-29 | $21.00 | $113K | -32.1% | -0.5% | -57.0% |
| OMED | SELL · 10b5-1 | 2015-07-28 | 2015-07-29 | $21.00 | $38K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2015-06-29 | 2015-06-30 | $22.67 | $41K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2015-05-27 | 2015-05-28 | $23.07 | $42K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2015-04-27 | 2015-04-29 | $25.65 | $46K | -32.1% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.